4D Molecular Therapeutics's total assets for Q1 2025 were $515.73M, a decrease of -7.97% from the previous quarter. FDMT total liabilities were $46.01M for the fiscal quarter, a -7.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.